These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21875319)

  • 21. Comparison between two treatment protocols with recombinant human erythropoietin (rHuEpo) in the treatment of late anemia in neonates with Rh-isoimmunization.
    Zuppa AA; Alighieri G; Fracchiolla A; Catenazzi P; D'Antuono A; Riccardi R; Cavani M; Romagnoli C
    Pediatr Med Chir; 2012; 34(4):186-91. PubMed ID: 23173411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease.
    Zuppa AA; Maragliano G; Scapillati ME; Florio MG; Girlando P; Noia G; De Santis M; Cavaliere AF; Romagnoli C; Tortorolo G
    Fetal Diagn Ther; 1999; 14(5):270-4. PubMed ID: 10529568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
    Ovali F; Samanci N; Dağoğlu T
    Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythropoietin in the pathogenesis and treatment of neonatal anemia.
    Strauss RG
    Transfusion; 1995 Jan; 35(1):68-73. PubMed ID: 7998075
    [No Abstract]   [Full Text] [Related]  

  • 26. Late Hyporegenerative Anemia Following Successful Management of Rh-D Alloimmunization: Still an Underappreciated Entity.
    Thomsen WC; Afify ZA
    Clin Pediatr (Phila); 2021 Sep; 60(9-10):399-402. PubMed ID: 34098759
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
    Takashina N; Kondo H; Kashiwazaki S
    J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum erythropoietin concentrations fail to increase after significant phlebotomy losses in ill preterm infants.
    Ohls RK; Harcum J; Li Y; Davila G; Christensen RD
    J Perinatol; 1997; 17(6):465-7. PubMed ID: 9447534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal anemia.
    Aher S; Malwatkar K; Kadam S
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):239-47. PubMed ID: 18411074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility.
    Schild RL; Hoch J; Plath H; Geissen C; Fahnenstich H; Dame C; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Jul; 14(1):64-7. PubMed ID: 10461341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated early onset anemia after rh isoimmunization: a unique presentation in 3 neonates.
    Louis D; Oberoi S; Sundaram V; Trehan A
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e230-2. PubMed ID: 20628321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant erythropoietin in very-low-birth-weight infants.
    Beck D; Calame A; Masserey E
    N Engl J Med; 1994 Sep; 331(10):676-7; author reply 677-8. PubMed ID: 8052281
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of transfusion in anemia of prematurity.
    Schwarz KB; Dear PR; Gill AB; Newell SJ; Richards M
    Pediatr Hematol Oncol; 2005; 22(7):551-9. PubMed ID: 16166047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant erythropoietin in very-low-birth-weight infants.
    Carnielli VP; Da Riol R; Montini G
    N Engl J Med; 1994 Sep; 331(10):677; author reply 677-8. PubMed ID: 8052282
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of neonatal anemia with recombinant human erythropoietin: a cost-benefit analysis].
    Schefels J; Merz U; Hörnchen H
    Z Geburtshilfe Neonatol; 1999 Dec; 203 Suppl 2():1-5. PubMed ID: 10612190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a role for erythropoietin in neonatal medicine?
    Mainie P
    Early Hum Dev; 2008 Aug; 84(8):525-32. PubMed ID: 18653293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anemia of prematurity and the decision when to transfuse.
    Stockman JA
    Adv Pediatr; 1983; 30():191-219. PubMed ID: 6369939
    [No Abstract]   [Full Text] [Related]  

  • 38. Current controversies in the management of the anemia of prematurity.
    Bishara N; Ohls RK
    Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
    Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
    An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.